{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:29:24Z","timestamp":1784665764799,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003400","name":"Ontario Ministry of Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003400","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health"},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["NIH\/NIDA R21"],"award-info":[{"award-number":["NIH\/NIDA R21"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["DA036024"],"award-info":[{"award-number":["DA036024"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["TMH109787"],"award-info":[{"award-number":["TMH109787"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.biopsych.2016.04.012","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T20:55:55Z","timestamp":1462049755000},"page":"691-701","source":"Crossref","is-referenced-by-count":80,"title":["Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB"],"prefix":"10.1016","volume":"80","author":[{"given":"Isabelle","family":"Boileau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris E.","family":"Payer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2016.04.012_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.biopsych.2016.04.012_bib2","unstructured":"United Nations Office on Drugs and Crime, World Drug Report 2015 (United Nations publication, Sales No. E.15.XI.6)."},{"key":"10.1016\/j.biopsych.2016.04.012_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/add.12703","article-title":"What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?","volume":"110","author":"Hall","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2016.04.012_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1521-0391.2013.00321.x","article-title":"Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample","volume":"22","author":"Lev-Ran","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2016.04.012_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08897070802218166","article-title":"Marijuana neurobiology and treatment","volume":"29","author":"Elkashef","year":"2008","journal-title":"Subst Abus"},{"key":"10.1016\/j.biopsych.2016.04.012_bib6","first-page":"CD008940","article-title":"Pharmacotherapies for cannabis dependence","volume":"12","author":"Marshall","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2016.04.012_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2016.04.012_bib8","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2016.04.012_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2016.04.012_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0006-2952(93)90486-G","article-title":"Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist","volume":"46","author":"Deutsch","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2016.04.012_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-319-20825-1_4","article-title":"The potential of inhibitors of endocannabinoid metabolism for drug development: A critical review","volume":"231","author":"Fowler","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib13","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1021\/jm800311k","article-title":"Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors","volume":"51","author":"Seierstad","year":"2008","journal-title":"J Med Chem"},{"issue":"Pt B","key":"10.1016\/j.biopsych.2016.04.012_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2013.07.026","article-title":"More surprises lying ahead. The endocannabinoids keep us guessing","volume":"76","author":"Piomelli","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2016.04.012_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2016.04.012_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2008.07.018","article-title":"The endocannabinoid system as a target for the treatment of cannabis dependence","volume":"56","author":"Clapper","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2016.04.012_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1208\/s12248-009-9110-7","article-title":"Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.biopsych.2016.04.012_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2013.01.003","article-title":"Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction","volume":"138","author":"Panlilio","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2016.04.012_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.04.012_bib21","doi-asserted-by":"crossref","first-page":"e60231","DOI":"10.1371\/journal.pone.0060231","article-title":"Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: Validation in clinical studies","volume":"8","author":"Zanotti-Fregonara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2016.04.012_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pbb.2005.01.028","article-title":"Cannabinoid tolerance and dependence: A review of studies in laboratory animals","volume":"81","author":"Gonzalez","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2016.04.012_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0006-8993(93)90220-H","article-title":"Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study","volume":"616","author":"Oviedo","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2016.04.012_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.105.019612","article-title":"Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration","volume":"70","author":"Sim-Selley","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neuroscience.2006.11.012","article-title":"Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain","volume":"145","author":"Villares","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2016.04.012_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bdrb.20295","article-title":"Effects of chronic bhang (cannabis) administration on the reproductive system of male mice","volume":"92","author":"Banerjee","year":"2011","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib27","first-page":"92","article-title":"Normal aging in rats and pathological aging in human Alzheimer\u2019s disease decrease FAAH activity: Modulation by cannabinoid agonists","volume":"60","author":"Pascual","year":"2014"},{"key":"10.1016\/j.biopsych.2016.04.012_bib28","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/j.1460-9568.2007.05900.x","article-title":"CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC\/MS) in the rat hypothalamus","volume":"26","author":"Bequet","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2016.04.012_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.112.121178","article-title":"Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms","volume":"202","author":"Morgan","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2016.04.012_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.04.012_bib31","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1471-4159.2000.0741627.x","article-title":"Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats","volume":"74","author":"Di Marzo","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2016.04.012_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2003.12.011","article-title":"Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence","volume":"74","author":"Gonzalez","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.04.012_bib33","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1038\/tp.2012.122","article-title":"Susceptibility of the adolescent brain to cannabinoids: Long-term hippocampal effects and relevance to schizophrenia","volume":"2","author":"Gleason","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2016.04.012_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2007.06.047","article-title":"Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2","volume":"573","author":"Castelli","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib35","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2016.04.012_bib36","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/hmg\/ddh216","article-title":"Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use","volume":"13","author":"Chiang","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2016.04.012_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ajmg.b.30491","article-title":"The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: Studies of drug use and dependence in Caucasians","volume":"144B","author":"Tyndale","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2016.04.012_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00213-008-1397-z","article-title":"Intermediate cannabis dependence phenotypes and the FAAH C385A variant: An exploratory analysis","volume":"203","author":"Schacht","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.04.012_bib39","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/j.1360-0443.2008.02292.x","article-title":"Marijuana withdrawal and craving: Influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes","volume":"103","author":"Haughey","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2016.04.012_bib40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/npp.2009.200","article-title":"Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues","volume":"35","author":"Filbey","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.04.012_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nicl.2015.03.024","article-title":"Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adults","volume":"8","author":"Shollenbarger","year":"2015","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.biopsych.2016.04.012_bib42","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/jcbfm.2015.119","article-title":"The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB","volume":"35","author":"Boileau","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2016.04.012_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nucmedbio.2010.08.001","article-title":"[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography","volume":"38","author":"Wilson","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib44","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/jcbfm.2015.133","article-title":"Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: A positron emission tomography study with the novel radioligand [(11)C]CURB","volume":"35","author":"Boileau","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2016.04.012_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/jcbfm.2012.180","article-title":"Mapping human brain fatty acid amide hydrolase activity with PET","volume":"33","author":"Rusjan","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2016.04.012_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1373\/clinchem.2012.195503","article-title":"Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers\u2019 blood on per se drugged driving laws","volume":"59","author":"Bergamaschi","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.biopsych.2016.04.012_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1373\/clinchem.2013.214106","article-title":"Urinary cannabinoid disposition in occasional and frequent smokers: Is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?","volume":"60","author":"Desrosiers","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.biopsych.2016.04.012_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jat\/33.8.469","article-title":"Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers","volume":"33","author":"Karschner","year":"2009","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib49","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/j.1360-0443.2009.02705.x","article-title":"Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?","volume":"104","author":"Karschner","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2016.04.012_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","article-title":"Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure","volume":"105","author":"Lowe","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.04.012_bib51","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1373\/clinchem.2011.171777","article-title":"Identification of recent cannabis use: Whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration","volume":"57","author":"Schwope","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.biopsych.2016.04.012_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2008.12.010","article-title":"Reliability and validity of a short form of the Marijuana Craving Questionnaire","volume":"102","author":"Heishman","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.04.012_bib53","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","article-title":"Marijuana withdrawal among adults seeking treatment for marijuana dependence","volume":"94","author":"Budney","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2016.04.012_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/10826088109038841","article-title":"Validity of alcoholic\u2019s self-reports: Duration data","volume":"16","author":"Cooper","year":"1981","journal-title":"Int J Addict"},{"key":"10.1016\/j.biopsych.2016.04.012_bib55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.15288\/jsad.2013.74.867","article-title":"Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems","volume":"74","author":"Bidwell","year":"2013","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.biopsych.2016.04.012_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drugalcdep.2012.12.016","article-title":"Working memory and impulsivity predict marijuana-related problems among frequent users","volume":"131","author":"Day","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.04.012_bib57","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00216-011-5197-7","article-title":"Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry","volume":"401","author":"Schwope","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.biopsych.2016.04.012_bib58","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2967\/jnumed.114.146464","article-title":"Whole-body radiation dosimetry of 11C-carbonyl-URB694: A PET tracer for fatty acid amide hydrolase","volume":"55","author":"Boileau","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2016.04.012_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","article-title":"An automated method for the extraction of regional data from PET images","volume":"147","author":"Rusjan","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2016.04.012_bib60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neuroscience.2009.06.043","article-title":"Temporal changes in mouse brain fatty acid amide hydrolase activity","volume":"163","author":"Glaser","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2016.04.012_bib61","doi-asserted-by":"crossref","first-page":"e53127","DOI":"10.1371\/journal.pone.0053127","article-title":"Psychomotor function in chronic daily Cannabis smokers during sustained abstinence","volume":"8","author":"Bosker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2016.04.012_bib62","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jat\/29.8.842","article-title":"THC can be detected in brain while absent in blood","volume":"29","author":"Mura","year":"2005","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib63","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib64","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2016.04.012_bib65","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1523\/JNEUROSCI.1937-15.2015","article-title":"Enhanced functional activity of the cannabinoid type-1 receptor mediates adolescent behavior","volume":"35","author":"Schneider","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2016.04.012_bib66","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.febslet.2007.05.037","article-title":"Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators","volume":"581","author":"Tham","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biopsych.2016.04.012_bib67","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1523\/JNEUROSCI.4830-06.2007","article-title":"Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells","volume":"27","author":"Muccioli","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2016.04.012_bib68","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopsych.2016.04.012_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbi.2014.01.018","article-title":"Immune system: A possible nexus between cannabinoids and psychosis","volume":"40","author":"Suarez-Pinilla","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2016.04.012_bib70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1191\/0960327104ht426oa","article-title":"Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students","volume":"23","author":"El-Gohary","year":"2004","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.111.180257","article-title":"Mechanistic and pharmacological characterization of PF-04457845: A highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain","volume":"338","author":"Ahn","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2016.04.012_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/ml100190t","article-title":"Discovery of PF-04457845: A highly potent, orally bioavailable, and selective urea FAAH inhibitor","volume":"2","author":"Johnson","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.biopsych.2016.04.012_bib73","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2125.2011.04137.x","article-title":"Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects","volume":"73","author":"Li","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2016.04.012_bib74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biopsych.2015.12.021","article-title":"Interactions between anandamide and corticotropin-releasing hormone signaling modulate human amygdala function and risk for anxiety disorders: An Imaging genetics strategy for modeling molecular interactions","volume":"80","author":"Demers","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.04.012_bib75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2016.01.004","article-title":"Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function","volume":"66","author":"Gray","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2016.04.012_bib76","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.biopsych.2016.04.012_bib77","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/ncomms7395","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"6","author":"Dincheva","year":"2015","journal-title":"Nat Commun"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322316323009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322316323009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T11:58:33Z","timestamp":1536753513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322316323009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0006322316323009"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2016.04.012","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}